Encapsulation method of biomass-based encapsulation material for probiotic activity protection

By employing a double-layer encapsulation method, utilizing a double-layer structure constructed from metal-polyphenol nanoparticles and proteins, the problem of insufficient protection for probiotics in the gastrointestinal environment was solved, thereby improving the survival rate and stability of probiotics and reducing preparation costs.

CN118903041APending Publication Date: 2024-11-08ZHEJIANG UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411154242.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Current probiotic encapsulation materials have poor protective effects in the gastrointestinal environment, insufficient biocompatibility and degradability, high preparation costs, and difficulty in achieving precise control, which affects the stability and efficacy of probiotic preparations.

Method used

A double-layer encapsulation method is adopted. First, a single layer of encapsulation is formed on the surface of probiotics using metal-polyphenol nanoparticles. Then, a second layer of encapsulation is constructed in the presence of proteins to form a double-layer structure, ensuring the activity protection of probiotics under various harsh environments.

Benefits of technology

It achieves highly efficient protection of probiotics in the gastrointestinal tract, under oxidative damage and antibiotic environments, maintains good biocompatibility and biodegradability, reduces preparation costs, and improves the survival rate and stability of probiotics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903041A_ABST
    Figure CN118903041A_ABST
Patent Text Reader

Abstract

The invention relates to an encapsulation method of a biomass-based encapsulation material for probiotic activity protection, which comprises the following steps: S1, in a buffer solution, polyphenol reacts under the chelation of metal salt to obtain metal-polyphenol nanoparticles; s2, carrying out first encapsulation on the probiotics in the presence of the metal-polyphenol nanoparticles, and after encapsulation is finished, carrying out post-treatment to obtain single-layer encapsulated probiotics; and S3, carrying out secondary encapsulation on the single-layer encapsulated probiotics in the presence of protein, and after the encapsulation is finished, carrying out post-treatment to obtain the double-layer encapsulated probiotics. According to the invention, the activity of probiotics in a plurality of severe gastrointestinal tract simulation environments such as gastrointestinal tract environment, oxidative damage environment and antibiotic environment can be ensured, and good biocompatibility and biodegradability are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pharmaceutical preparations, and in particular to an encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics. Background Art

[0002] Probiotics are generally a type of microorganisms that are beneficial to the human body and can be prepared into food, medicine, and health products. In recent years, the probiotic industry has flourished and has great application potential in the fields of medicine and health care. Among various drug delivery methods, oral delivery is the most suitable for the delivery of probiotic preparations. However, this also means that probiotics must pass through the acidic gastric environment and the harsh environment rich in various hydrolytic enzymes to reach the intestinal tract to exert their effects.

[0003] Bacterial surface modification refers to the process of improving various properties of bacteria by wrapping or attaching some materials on the surface of bacteria. Through the surface modification of bacteria, their resistance in various aspects can be significantly improved. However, many existing surface modification technologies often have problems such as poor biocompatibility, difficulty in material preparation, and expensive preparation materials. Although it can provide valuable information and ideas to subsequent researchers, it is difficult to apply in the actual drug delivery process. This study proposed a bacterial surface modification scheme formed by a double-layer coating assembly. In in vitro aqueous solution experiments, it can demonstrate resistance to various harsh gastrointestinal simulated environments such as simulated gastrointestinal environment, oxidative damage environment, and antibiotic environment. After refrigeration, it can help the bacterial activity to recover quickly, and has good prospects for application in the oral delivery of probiotics.

[0004] A Chinese patent with authorization announcement number CN113499325B discloses a biomass-based encapsulation material and an encapsulation method for protecting the activity of probiotics, including a nanofilm for encapsulating probiotics; the nanofilm includes two layers, the first layer is formed in situ by natural bio-based polymers and metal ions on the surface of probiotics through covalent crosslinking or metal chelation; the second layer is formed by the interaction between biological enzymes and natural bio-based polymers; the nanofilm formed in situ on the cell wall of probiotics in the present invention is used for encapsulation and protection of probiotics; the nanofilm is composed of natural biomass, low cost, and no toxic side effects; the encapsulated probiotics can have a relative activity close to or even higher than 90% whether cultivated in a high concentration of antibiotics or an active free radical environment, while the relative activity of unprotected probiotics is below 30%, or even completely unable to survive.

[0005] The above-mentioned existing technical solutions have the following defects: although the above-mentioned encapsulation method can provide a certain protection effect, its protection mechanism is still not perfect enough and cannot completely resist the destruction of gastric acid and enzymes, resulting in a low survival rate of probiotics during the delivery process; the biocompatibility and biodegradability of the encapsulation material still need to be improved to ensure that the probiotics are harmless to the human body after delivery and can be completely degraded in the body; the controllability of the encapsulation process is poor, and the preparation cost is high, it is difficult to achieve precise regulation of the protection of probiotic activity, which affects the stability and effectiveness of the probiotic preparation and needs to be improved. Summary of the invention

[0006] The problem to be solved by the present invention is to provide an encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics in response to the above-mentioned deficiencies in the prior art, which can ensure the activity of probiotics in various severe gastrointestinal simulated environments such as gastrointestinal environment, oxidative damage environment, antibiotic environment, etc., and has good biocompatibility and biodegradability.

[0007] The above-mentioned object of the present invention is achieved through the following technical solutions: A method for encapsulating a biomass-based encapsulating material for protecting the activity of probiotics, comprising the following steps: S1 In a buffer solution, polyphenols react under the chelation of metal salts to obtain metal-polyphenol nanoparticles; S2 probiotics are first encapsulated in the presence of the metal-polyphenol nanoparticles, and then post-processed after encapsulation to obtain single-layer encapsulated probiotics; The single-layer encapsulated probiotics in S3 are encapsulated for a second time in the presence of protein, and are post-processed after encapsulation to obtain double-layer encapsulated probiotics.

[0008] Furthermore, in S1, the buffer is 10 mM phosphate buffer, the polyphenol is tannic acid, and the metal ion in the metal salt is Fe 2+ or Fe 3+ .

[0009] Furthermore, in S1, the molar ratio of polyphenol to metal salt is controlled to be 1-2:1.0.

[0010] Furthermore, in the S1, 0.4-2.0 mL of a 5 mg / mL polyphenol aqueous solution is first added to a 10 mL, 10 mM phosphate buffer, and magnetically stirred for 4-6 min, and then 95-190 μL of a 10 mg / mL metal salt aqueous solution is added, and magnetically stirred for 10-30 min to obtain a chelating solution of metal-polyphenol nanoparticles.

[0011] Furthermore, in S2, the probiotics are 1×10 7 ~2×109 CFU of Escherichia coli Nissle 1917.

[0012] Furthermore, in S2, 1×10 7 ~2×10 9 CFU of probiotics, magnetic stirring for 50-70 min to obtain single-layer encapsulated probiotics.

[0013] Furthermore, in S2, the post-treatment includes first centrifuging the mixed solution containing the monolayer encapsulated probiotics at 1000-5000 rpm to collect the probiotics, then adding water or phosphate buffer to resuspend the probiotics and centrifuging again, and repeating 1-3 times.

[0014] Furthermore, in S3, the protein is silk fibroin.

[0015] Furthermore, in S3, 10 mL of 1-10 mg / mL protein aqueous solution is added to the single-layer encapsulated probiotics obtained in S2, and magnetic stirring is performed for 60-120 min to obtain double-layer encapsulated probiotics.

[0016] Furthermore, in S3, the post-treatment includes firstly subjecting the mixed solution containing the double-layer encapsulated probiotics to centrifugation at 1000-5000 rpm to collect the probiotics, then adding water or phosphate buffer to resuspend the probiotics and centrifuging again, and repeating 1-3 times.

[0017] Specifically, the following steps are included: S1 was added to 10 mL of 10 mM phosphate buffer solution, 0.4-2.0 mL of 5 mg / mL tannic acid aqueous solution was first added, magnetic stirring was performed for 4-6 min, and then 95-190 μL of 10 mg / mL metal salt aqueous solution was added, magnetic stirring was performed for 10-30 min, to obtain a chelating solution of metal-polyphenol nanoparticles; S2: Add 1×10 7 ~2×10 9 CFU of Escherichia coli Nissle 1917, magnetic stirring for 50-70 minutes, and then centrifugation at 1000-5000 rpm to collect the probiotics, and then add water or phosphate buffer to resuspend the probiotics and centrifuge again, repeat 1-3 times to obtain a single-layer encapsulated probiotic; S3: First, add 10 mL of 1-10 mg / mL silk fibroin aqueous solution to the single-layer encapsulated probiotics obtained in S2, stir magnetically for 60-120 min, and then collect the probiotics by centrifugation at 1000-5000 rpm. Then, add water or phosphate buffer to resuspend the probiotics and centrifuge again. Repeat 1-3 times to obtain double-layer encapsulated probiotics.

[0018] In summary, the beneficial technical effects of the present invention are: The present invention achieves encapsulation and protection of probiotics by constructing a double-layer modified structure on the surface of probiotics. The first layer is composed of nanoparticles formed by chelation of metal ions and polyphenols. The structural components of this layer are widely available and low in cost. The second layer is composed of protein and has good biocompatibility. The construction process does not require the use of organic solvents and useless ligands, ensuring the excellent biocompatibility and non-toxic side effects of the system. The probiotics prepared by the technology of the present invention can still show excellent protection effects on the probiotics in a variety of severe gastrointestinal simulated environments such as simulated gastrointestinal environment, oxidative damage environment, antibiotic environment, etc., which is conducive to the application of probiotics in oral drug delivery; The packaging material provided by the present invention can effectively prevent the probiotics from being damaged under various storage conditions such as room temperature, refrigeration, and freezing, thereby facilitating the long-term preservation of the probiotics. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 This is a TEM image of the double-layer encapsulated probiotics prepared in Example 1 of the present invention.

[0020] Figure 2 This is a SGF tolerance test chart of the double-layer encapsulated probiotics prepared in Example 1 of the present invention.

[0021] Figure 3 This is a SIF tolerance test chart of the double-layer encapsulated probiotics prepared in Example 1 of the present invention.

[0022] Figure 4 This is a hydrogen peroxide tolerance test chart of the double-layer encapsulated probiotics prepared in Example 1 of the present invention.

[0023] Figure 5 This is a test chart of the recovery activity of the double-layer encapsulated probiotics prepared in Example 1 of the present invention after being frozen at -20°C.

[0024] Figure 6 This is a test chart of the recovery activity of the double-layer encapsulated probiotics prepared in Example 1 of the present invention after being frozen at 25°C.

[0025] Figure 7 This is a test chart of the recovery activity of the double-layer encapsulated probiotics prepared in Example 1 of the present invention after being frozen at 4°C. DETAILED DESCRIPTION

[0026] In order to make the technical means, creative features, objectives and functions achieved by the present invention clearer and easier to understand, the present invention is further explained below in conjunction with the accompanying drawings and specific implementation methods. Example

[0027] Example 1: An encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, comprising the following steps: S1 was added to 10 mL of 10 mM phosphate buffer solution, 2.0 mL of 5 mg / mL tannic acid aqueous solution was first added, magnetic stirring was performed for 5 min, and then 95 μL of 10 mg / mL ferric chloride aqueous solution was added, and magnetic stirring was performed for 20 min to obtain a chelating solution of metal-polyphenol nanoparticles; S2: In the chelating solution obtained in S1, 2 mL, 2×10 9 CFU of Escherichia coli Nissle 1917, magnetic stirring for 60 minutes, and then centrifugation at 3000 rpm to collect the probiotics, and then add water or phosphate buffer to resuspend the probiotics and centrifuge again, repeating twice to obtain a single-layer encapsulated probiotic; S3: First, add 10 mL of 10 mg / mL silk fibroin aqueous solution to the single-layer encapsulated probiotics obtained in S2, stir magnetically for 90 min, collect the probiotics by centrifugation at 3000 rpm, then add water or phosphate buffer to resuspend the probiotics and centrifuge again, repeat twice to obtain double-layer encapsulated probiotics.

[0028] Examples 2 to 6 are encapsulation methods for biomass-based encapsulation materials for protecting the activity of probiotics disclosed in the present invention. The difference from Example 1 is that in S1, the molar ratios of polyphenols and metal salts are controlled to be 1.0, 1.2, 1.5, 1.8, and 2.0:1.0, respectively.

[0029] Example 7: An encapsulation method for a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, which is different from Example 1 in that the ferric chloride aqueous solution is replaced by a ferrous chloride tetrahydrate aqueous solution.

[0030] Examples 8 to 12 are encapsulation methods for biomass-based encapsulation materials for protecting the activity of probiotics disclosed in the present invention. The difference from Example 1 is that 1×10 7 , 5×10 7 , 1×10 8 , 5×10 8 , 1×10 9 CFU of Escherichia coli Nissle 1917.

[0031] Examples 13 to 16 are encapsulation methods for biomass-based encapsulation materials for protecting the activity of probiotics disclosed in the present invention. The difference from Example 1 is that 1, 2, 5, and 8 mg / mL of silk fibroin aqueous solution are added to S3, respectively.

[0032] Comparative Example 1: An encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, which is different from Example 1 in that no polyphenol aqueous solution is used.

[0033] Comparative Examples 2 to 7 are encapsulation methods for a biomass-based encapsulation material for active protection of probiotics disclosed in the present invention, which are different from Example 1 in that the Fe ions in the ferric chloride aqueous solution are replaced by Al, Zn, Mn, Ni, Co, and V ions.

[0034] Comparative Example 8: An encapsulation method for a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, which is different from Example 1 in that the molar ratio of polyphenols to metal salts is controlled to be 5.0:1.0, respectively.

[0035] Comparative Example 9: An encapsulation method for a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, which is different from Example 1 in that no silk fibroin aqueous solution is used.

[0036] Comparative Example 10: An encapsulation method for a biomass-based encapsulation material for protecting the activity of probiotics disclosed in the present invention, which is different from Example 1 in that the silk fibroin in the silk fibroin aqueous solution is replaced by trypsin.

[0037] The effects of different environmental pressures on the activities of Escherichia coli Nissle 1917 encapsulated in Example 1 and Comparative Example 9 and unencapsulated Escherichia coli Nissle 1917 were tested. The activities were detected according to the following 6 methods, each method was measured in parallel 3 times, and the results are shown in Table 1.

[0038] (1) Dilute the bacteria to 1×10 7 Take 100 μL of the solution and add it to 900 μL of simulated gastric fluid for the corresponding time, then dilute and spread on the plate. Incubate the plate upside down at 37°C and count the cells overnight.

[0039] (2) Dilute the bacteria to 1×10 7 Take 100 μL of the solution and add it to 900 μL of simulated intestinal fluid for the corresponding time, then dilute and spread on the plate. Place the plate upside down and culture at 37°C, and count after overnight.

[0040] (3) Dilute the bacteria to 1×107 Take 100 μL of the solution and add it to 900 μL of 500 μM hydrogen peroxide solution for the corresponding time, then dilute and spread on the plate. Incubate the plate upside down at 37°C and count overnight.

[0041] (4) Bacteria stored at 4°C (theoretical concentration before storage is 1×10 8 CFU / mL) was taken and inoculated into 50 mL of LB medium and cultured in a shaking incubator at 37°C and 200 rpm. Samples were taken at different time points to measure the OD value of the recovery activity after storage. 600 , make a bacterial growth curve.

[0042] (5) Bacteria stored at -20°C (theoretical concentration before storage was 1×10 8 CFU / mL) was taken and inoculated into 50 mL of LB medium and cultured in a shaking incubator at 37°C and 200 rpm. Samples were taken at different time points to measure the OD value of the recovery activity after storage. 600 , make a bacterial growth curve.

[0043] (6) Bacteria stored at 25°C (theoretical concentration before storage is 1×10 8 CFU / mL) was taken and inoculated into 50 mL of LB medium and cultured in a shaking incubator at 37°C and 200 rpm. Samples were taken at different time points to measure the OD value of the recovery activity after storage. 600 , make a bacterial growth curve.

[0044] Table 1 Untreated probiotics-1 Untreated Probiotics-2 Unprocessed Probiotics-3 Example 1-1 Example 1-2 Examples 1-3 Comparative Example 9-1 Comparative Example 9-2 Comparative Example 9-3 SGF survival rate / %, 0.5h 5.581395349 6.279069767 4.88372093 69.76744186 83.72093023 83.72093023 59.30232558 62.79069767 60.69767442 SGF survival rate / %, 2.0h 0.844186047 0.81627907 0.76744186 43.25581395 49.3255814 41.79069767 14.86046512 31.95348837 33.8372093 SGF survival rate / %, 4.0h 0.087209302 0.069069767 0.057209302 28.95348837 36.34883721 38.44186047 23.09302326 35.51162791 37.81395349 SIF survival rate / %, 2.0h 69.76744186 83.72093023 90.69767442 97.6744186 104.6511628 125.5813953 90.69767442 104.6511628 111.627907 SIF survival rate / %, 4.0h 47.51162791 44.30232558 43.81395349 44.58139535 46.74418605 46.39534884 42.62790698 48.27906977 44.1627907 Bacterial counts after hydrogen peroxide treatment <![CDATA[2.37×10 7 ]]> <![CDATA[2.2×10 7 ]]> <![CDATA[2.33×10 7 ]]> <![CDATA[8.3×10 7 ]]> <![CDATA[9.7×10 7 ]]> <![CDATA[8.2×10 7 ]]> <![CDATA[4.4×10 7 ]]> <![CDATA[5.9×10 7 ]]> <![CDATA[4.1×10 7 <!-- 4 -->]]> <h2 style=";text-align:left;direction:ltr"><![CDATA[OD <h2 style=";text-align:left;direction:ltr"> 600 <h2 style=";text-align:left;direction:ltr"> -20℃,360min<h2 style=";text-align:left;direction:ltr"> 0.747 0.764 0.768 0.91 0.908 0.904 0.837 0.838 0.846 <![CDATA[OD 600 ,4℃,300min]]> 0.316 0.315 0.312 0.524 0.52 0.531 0.465 0.49 0.491 <![CDATA[OD 600 ,25℃,300min]]> 0.237 0.262 0.26 0.631 0.641 0.658 0.563 0.561 0.564 As can be seen from Table 1, after encapsulation, the bacterial activity of Escherichia coli Nissle 1917 treated in adverse environments such as simulated gastrointestinal tract and hydrogen peroxide can be greatly increased, and the bacterial activity after double-layer coating exceeds that of single-layer coated bacteria, indicating that the present invention ensures that probiotics have good potential to assist drug delivery in various severe gastrointestinal simulated environments such as gastrointestinal environment and oxidative damage environment.

[0045] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution of the present invention, which should be included in the scope of the claims of the present invention.

Claims

1. A method for encapsulating a biomass-based encapsulating material for protecting the activity of probiotics, characterized in that: The following steps are included: S1 In a buffer solution, polyphenols react under the chelation of metal salts to obtain metal-polyphenol nanoparticles; S2 probiotics are first encapsulated in the presence of the metal-polyphenol nanoparticles, and then post-processed after encapsulation to obtain single-layer encapsulated probiotics; The single-layer encapsulated probiotics in S3 are encapsulated for a second time in the presence of protein, and are post-processed after encapsulation to obtain double-layer encapsulated probiotics.

2. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 1, characterized in that: In S1, the buffer is 10 mM phosphate buffer, the polyphenol is tannic acid, and the metal ion in the metal salt is Fe 2+ or Fe 3+ .

3. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 2, characterized in that: In the S1, the molar ratio of polyphenol to metal salt is controlled to be 1-2:1.

0.

4. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 3, characterized in that: In the S1, 0.4-2.0 mL of a 5 mg / mL polyphenol aqueous solution is first added to a 10 mL, 10 mM phosphate buffer, and magnetic stirring is performed for 4-6 min. Then, 95-190 μL of a 10 mg / mL metal salt aqueous solution is added, and magnetic stirring is performed for 10-30 min to obtain a chelating solution of metal-polyphenol nanoparticles.

5. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 1, characterized in that: In S2, the probiotics were 1×10 7 ~2×10 9 CFU of Escherichia coli Nissle 1917.

6. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 5, characterized in that: In S2, 1×10 7 ~2×10 9 CFU of probiotics, magnetic stirring for 50-70 min to obtain single-layer encapsulated probiotics.

7. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 6, characterized in that: In S2, the post-treatment includes first subjecting the mixed solution containing the monolayer encapsulated probiotics to centrifugation at 1000-5000 rpm to collect the probiotics, then adding water or phosphate buffer to resuspend the probiotics and centrifuging again, and repeating 1-3 times.

8. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 1, characterized in that: In the S3, the protein is silk fibroin.

9. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 8, characterized in that: In S3, 10 mL of 1-10 mg / mL protein aqueous solution is added to the single-layer encapsulated probiotics obtained in S2, and magnetic stirring is performed for 60-120 min to obtain double-layer encapsulated probiotics.

10. The encapsulation method of a biomass-based encapsulation material for protecting the activity of probiotics according to claim 9, characterized in that: In S3, the post-treatment includes first subjecting the mixed solution containing the double-layer encapsulated probiotics to centrifugation at 1000-5000 rpm to collect the probiotics, then adding water or phosphate buffer to resuspend the probiotics and centrifuging again, and repeating 1-3 times.